<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: In the United States in 2012, there were 16,060 new cases of <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (CLL) </plain></SENT>
<SENT sid="1" pm="."><plain>Often CLL is clinically occult and first detected during pathologic evaluation of the sentinel lymph node biopsy (SLNB) </plain></SENT>
<SENT sid="2" pm="."><plain>We reviewed our experience of patients with the coexisting diagnosis of <z:hpo ids='HP_0002861'>melanoma</z:hpo> and CLL </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: An institutional review board-approved review was performed on patients with CLL and <z:hpo ids='HP_0002861'>melanoma</z:hpo> treated from 1995 to 2009 at Moffitt <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Center and compared with the incidence of <z:hpo ids='HP_0002861'>melanoma</z:hpo> and CLL in our <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> registry patients with breast, prostate, lung, and <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Fifty-two patients (44 males; median age, 71 years [range, 46-88]) were identified with concurrent diagnoses of <z:hpo ids='HP_0002861'>melanoma</z:hpo> and CLL </plain></SENT>
<SENT sid="5" pm="."><plain>Twenty-two patients (42 %) had CLL on SLNB for their <z:hpo ids='HP_0002861'>melanoma</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Thirty-two patients (62 %) were diagnosed with <z:hpo ids='HP_0002861'>melanoma</z:hpo> before CLL </plain></SENT>
<SENT sid="7" pm="."><plain>Concomitant or prior <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnoses included <z:e sem="disease" ids="C0699893" disease_type="Neoplastic Process" abbrv="">nonmelanoma skin cancers</z:e> (N = 29), prostate (N = 6), colorectal (N = 2), and Merkel cell <z:mp ids='MP_0002038'>carcinoma</z:mp> (N = 2) </plain></SENT>
<SENT sid="8" pm="."><plain>Five of 20 patients (25 %) had metastatic <z:hpo ids='HP_0002861'>melanoma</z:hpo> found at the time of SLNB </plain></SENT>
<SENT sid="9" pm="."><plain>Patients with <z:hpo ids='HP_0002861'>melanoma</z:hpo> had a tenfold increase of CLL diagnosis compared with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients, an eightfold increase compared to <z:hpo ids='HP_0012125'>prostate cancer</z:hpo> patients, and a fourfold increase compared with <z:hpo ids='HP_0003002'>breast cancer</z:hpo> patients </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: We have confirmed an increased association of CLL and <z:hpo ids='HP_0002861'>melanoma</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>This may be related to an underlying immunologic defect; however, there has been scant investigation into this phenomenon </plain></SENT>
<SENT sid="12" pm="."><plain>Surgeons and pathologists should understand this occurrence and recognize that not <z:hpo ids='HP_0000001'>all</z:hpo> grossly enlarged or abnormal sentinel lymph nodes in <z:hpo ids='HP_0002861'>melanoma</z:hpo> patients represent <z:hpo ids='HP_0002861'>melanoma</z:hpo> </plain></SENT>
</text></document>